![Sung Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sung Lee
Finanzdirektor/CFO bei
CYTOKINETICS, INCORPORATED
Vermögen: 5 Mio $ am 31.05.2026
Profil
Sung H.
Lee is currently Lead Independent Director at Tango Therapeutics, Inc. since 2026 and Chief Financial Officer & Executive Vice President at Cytokinetics, Inc. since 2024.
Former positions include Chief Financial Officer & Executive Vice President at Vir Biotechnology, Inc. from 2023 to 2024, Chief Financial Officer at MorphoSys AG from 2021 to 2023, Chief Financial Officer & Executive Vice President at Sangamo Therapeutics, Inc. from 2019 to 2021, and Vice President-Investor Relations at Gilead Sciences, Inc. from 2016 to 2019.
Education includes graduate studies at the University of Southern California and undergraduate studies at the University of California, Irvine.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.05.2026 | 63 221 ( 0,05 % ) | 5 Mio $ | 31.05.2026 | |
TANGO THERAPEUTICS, INC. 0,02 % | 05.06.2026 | 22 870 ( 0,02 % ) | 502 683 $ | 31.05.2026 |
Aktive Positionen von Sung Lee
| Unternehmen | Position | Beginn |
|---|---|---|
| CYTOKINETICS, INCORPORATED | Finanzdirektor/CFO | 08.05.2024 |
| TANGO THERAPEUTICS, INC. | Direktor/Vorstandsmitglied | 05.01.2026 |
Ehemalige bekannte Positionen von Sung Lee
| Unternehmen | Position | Ende |
|---|---|---|
| VIR BIOTECHNOLOGY, INC. | Finanzdirektor/CFO | 03.05.2024 |
| MORPHOSYS AG | Finanzdirektor/CFO | 17.03.2023 |
| SANGAMO THERAPEUTICS, INC. | Finanzdirektor/CFO | 01.02.2021 |
| GILEAD SCIENCES, INC. | Investor Relations Kontakt | 31.10.2019 |
Ausbildung von Sung Lee
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
67
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
Cytokinetics, Inc.
 Cytokinetics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes novel drug products | Health Technology |
MorphoSys AG
 MorphoSys AG BiotechnologyHealth Technology Manufactures pharmaceutical products and provides research and development services | Health Technology |
University of Southern California
 University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vir Biotechnology, Inc.
 Vir Biotechnology, Inc. BiotechnologyHealth Technology Develops cures and treatments drug for viral & bacterial diseases | Health Technology |
Tango Therapeutics, Inc.
 Tango Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company that engages in discovering and delivering precision cancer medicines | Health Technology |
